BMEA Latest News, Press Relases and Analysis

All

Press Releases

20 days ago - By: Chartmill - Mentions: RVSN SPRB HUMA SGLY ...

Top stock movements in today's session.

20 days ago - By: Chartmill - Mentions: BTM AEHR APVO PCSA ...

Which stocks are moving on Tuesday?

13 hours ago - By: Biomea Fusion, Inc.

Biomea Fusion Announces First Patient Dosed in Phase I Study of BMF-650 a Next-Generation Oral GLP-1 Receptor Agonist

6 days ago - By: Biomea Fusion, Inc.

Biomea Fusion to Participate in Citi's SMID Biotech C-Suite Fireside Chat Series

6 days ago - By: Biomea Fusion, Inc.

Biomea Fusion to Participate in Citi's SMID Biotech C-Suite Fireside Chat Series

20 days ago - By: Benzinga - Mentions: SNWV CLRB APVO SPRB ...

12 Health Care Stocks Moving In Tuesday's Intraday Session

20 days ago - By: Benzinga

Biomea Fusion Stock Plummets Following Public Offering, Diabetes Study

20 days ago - By: Chartmill - Mentions: NAK ACET BTM AEHR ...

Tuesday's session: gap up and gap down stocks

21 days ago - By: Chartmill - Mentions: NAK NVX AEHR APVO ...

Stay updated with the stocks that are on the move in today's pre-market session.

21 days ago - By: Biomea Fusion, Inc.

Biomea Fusion Announces Pricing of Public Offering of Securities

21 days ago - By: Biomea Fusion, Inc.

Biomea Fusion Announces Pricing of Public Offering of Securities

21 days ago - By: Biomea Fusion, Inc.

Biomea Fusion Announces Proposed Public Offering of Securities

21 days ago - By: Biomea Fusion, Inc.

Biomea Fusion Announces Proposed Public Offering of Securities

21 days ago - By: Biomea Fusion, Inc.

Biomea Fusion Announces Positive 52-Week Results from Phase II COVALENT-111 Study in Type 2 Diabetes Demonstrating Non-Chronic Treatment with Icovamenib Benefits Two Distinct Patient Populations

21 days ago - By: Biomea Fusion, Inc.

Biomea Fusion Announces Positive 52-Week Results from Phase II COVALENT-111 Study in Type 2 Diabetes Demonstrating Non-Chronic Treatment with Icovamenib Benefits Two Distinct Patient Populations

a month ago - By: Biomea Fusion, Inc.

Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

a month ago - By: Biomea Fusion, Inc.

Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

a month ago - By: Biomea Fusion, Inc.

Biomea Fusion Presents Data Demonstrating Enhanced Preclinical Activity of Icovamenib in Combination with Semaglutide in Type 2 Diabetes (T2D) Animal Model at the 61st EASD Annual Meeting and Provides Additional Corporate Update

a month ago - By: Biomea Fusion, Inc.

Biomea Fusion Presents Data Demonstrating Enhanced Preclinical Activity of Icovamenib in Combination with Semaglutide in Type 2 Diabetes (T2D) Animal Model at the 61st EASD Annual Meeting and Provides Additional Corporate Update

2 months ago - By: Yahoo Finance - Mentions: UBS WYNN DB TIC ...

Five Below upgraded, Bill downgraded: Wall Street's top analyst calls

3 months ago - By: The Motley Fool

Biomea Fusion (BMEA) Q2 Loss Drops 44%

3 months ago - By: Biomea Fusion, Inc.

Biomea Fusion Reports Second Quarter 2025 Financial Results and Corporate Highlights

3 months ago - By: Biomea Fusion, Inc.

Biomea Fusion Reports Second Quarter 2025 Financial Results and Corporate Highlights

3 months ago - By: Biomea Fusion, Inc.

Biomea Fusion Appoints Julianne Averill to its Board of Directors

3 months ago - By: Biomea Fusion, Inc.

Biomea Fusion Appoints Julianne Averill to its Board of Directors

4 months ago - By: Biomea Fusion, Inc.

Biomea Fusion Presents New Preclinical and Clinical Data on Icovamenib at the 85th Scientific Sessions of the American Diabetes Association (ADA)

4 months ago - By: Biomea Fusion, Inc.

Biomea Fusion Presents New Preclinical and Clinical Data on Icovamenib at the 85th Scientific Sessions of the American Diabetes Association (ADA)

4 months ago - By: Biomea Fusion, Inc.

Biomea Fusion Reports Preclinical Data for BMF-650, a Next-Generation Oral GLP-1 Receptor Agonist Candidate, Demonstrating Robust Weight Loss and Appetite Suppression in Obese Non-Human Primates

BIOMEA FUSION INC (BMEA) Stock News

BMEA Latest News, Press Relases and Analysis